Interpretation
Interpretation
Interpretation
Avinash Dudpuri
Received Date & Time : 26/09/2021 14:50:28
Age : 30 YEARS Gender :Male
Printing Date & Time : 27/09/2021 11:50:24
Ref. By Dr. : Patient ID : 1621259
Ref. By Lab :
Company : PRIVATE DOCTOR
SRF ID 0708301559700
MOLECULAR*
COVID-19 VIRU S QUAL ITATIVE PCR*
FINAL RESULT OF SARS-CoV2 (COVID19) NEGATIVE
E GENE/N GENE(ABI KITS ONLY)/T NEGATIVE
RUNAT ORF1a/ORF1b/N/N2 GENE NEGATIVE
(FOR SEEGENE CEPHEID)
Interpretation
Result Interpretation
Positive RNA specific to SARS-Co V-2 Detected
Negative RNA specific to SARS-CoV-2 not detected
Inconclusive This could be due to presence of inhibitors in the sample. A repeat sample is
recommended in such cases after 3-5 days. Kindly correlate with duration of. illness
NOTE
1. ICMR Registration number for Covid -19 is UPDGND
2. Covid-19 Test conducted as per kits approved by ICMR / CE-IVD / USFDA
3. Real Time RT-PCR is the gold standard Frontline test for diagnosis of COVID-19.
4. COVID-19 is a Notifiable Disease. Detected positive cases have to follow the MOHFW guidelines of strict home isolation
along with other safety measures. Their presence in social places should be subject to as offensive action. The lab cannot
be held responsible for their any such action.
5. Target genes specific for SARS -CoV-2 included in the assay are : E/N gene, RdRp/ORF1 gene.
6. Confirmatory assay is performed and NOT just The SCREENING one
7. TAT is minimum 6 hrs and maximum 24 hrs varying on the sample collection site.
8. Test integrity check points :Strict cold chain maintained &Internal control gene used
9. Negative result does not rule out the possibility of Covid-19 infection. Presence of inhibitors, mutations & insufficient
RNA specific to SARS-CoV-2 can influence the test result. Kindly correlate the results with clinical findings. A negative
result in a single upper respiratory tract sample does not rule out SARS-CoV-2 infection. Hence in such cases a repeat
sample should be sent. If a subsequent sample is tested positive(DETECTED), it may indicate an infection acquired
subsequently/increase in viral load to detectable limit after the first test. Lower respiratory tract sampl es like Sputum, BAL,
ET aspirate are appropriate samples especially in severe and progressive lung disease.
10. Optimum specimen types and timing for peak viral levels during infections caused by 2019 -nCoV have not been determined. Collection
of multiple specimens (types and time points) from the same patient may be necessary to detect the virus. Note:
Page No: 1 of 2
Name Of Patient : MR. Avinash Dudpuri
Received Date & Time : 26/09/2021 14:50:28
Age : 30 YEARS Gender :Male
Printing Date & Time : 27/09/2021 11:50:24
Ref. By Dr. : Patient ID : 1621259
Ref. By Lab :
Company : PRIVATE DOCTOR
SRF ID 0708301559700
The results relate only to the specimens tested and should be correlated with clinical findings and the duration of illness.
11. Testing of referred clinical specimens was considered on the basis of request / referral received from / through State
Surveillance Officer (SSO) of concerned State Integrated Disease Surveillance Programme (IDSP)/ any other health care
facility affirming requirements of the case definition/s.
12. A positive alternate pathogen does not necessarily rule out either, as little is yet known about the role of coinfections.
13. INDETERMINATE results could be due to various reasons:
Page No: 2 of 2